About D-amino-acid oxidase
D-amino-acid oxidase (DAO) is a protein
from Homo sapiens identified by UniProt accession
P14920, 347 residues long.
MolForge cross-references it against 0 known binders and
116 disease associations.
Target properties
| Protein name | D-amino-acid oxidase |
| UniProt accession | P14920 |
| Gene | DAO |
| Organism | Homo sapiens |
| Length | 347 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (3)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (116)
Diseases linked to this target (Open Targets).
- amyotrophic lateral sclerosis · score 0.45
- schizophrenia · score 0.39
- Amyotrophic lateral sclerosis · score 0.37
- familial amyotrophic lateral sclerosis · score 0.37
- sporadic amyotrophic lateral sclerosis · score 0.37
- blood protein measurement · score 0.23
- neurodegenerative disease · score 0.22
- genetic disorder · score 0.19
- mean platelet volume · score 0.13
- cognitive function measurement · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P14920-F1 | alphafold | PREDICTED | 96.19 | — |
Amino-acid sequence (347 residues)
MRVVVIGAGV IGLSTALCIH ERYHSVLQPL DIKVYADRFT PLTTTDVAAG LWQPYLSDPN NPQEADWSQQ TFDYLLSHVH SPNAENLGLF LISGYNLFHE AIPDPSWKDT VLGFRKLTPR ELDMFPDYGY GWFHTSLILE GKNYLQWLTE RLTERGVKFF QRKVESFEEV AREGADVIVN CTGVWAGALQ RDPLLQPGRG QIMKVDAPWM KHFILTHDPE RGIYNSPYII PGTQTVTLGG IFQLGNWSEL NNIQDHNTIW EGCCRLEPTL KNARIIGERT GFRPVRPQIR LEREQLRTGP SNTEVIHNYG HGGYGLTIHW GCALEAAKLF GRILEEKKLS RMPPSHL
Explore D-amino-acid oxidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets